Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 34 articles: HTML format

Single Articles

May 2024
1. MUNIR T, Hillmen P
   Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply.
   N Engl J Med. 2024;390:1634-1635.
   PubMed    
   
   
   
2. WANG WD, Gale RP, Liang Y
   Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
   N Engl J Med. 2024;390:1633-1634.
   PubMed    
   
   
   
3. WINKLER C
   Acute Promyelocytic Leukemia.
   N Engl J Med. 2024;390:e42.
   PubMed    
   
   
   April 2024
4. BLAISE D
   CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.
   N Engl J Med. 2024;390:1526-1527.
   PubMed    
   
   
   
5. HU Y, Zhang M, Yang T, Mo Z, et al
   Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
   N Engl J Med. 2024;390:1467-1480.
   PubMed     Abstract available
   
   
   December 2023
6. MUNIR T, Cairns DA, Bloor A, Allsup D, et al
   Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
   N Engl J Med. 2023 Dec 10. doi: 10.1056/NEJMoa2310063.
   PubMed     Abstract available
   
   
   July 2023
7. KATER AP, Eichhorst B
   Inhibiting BTK in Chronic Lymphocytic Leukemia.
   N Engl J Med. 2023;389:83-86.
   PubMed    
   
   
   
8. MATO AR, Woyach JA, Brown JR, Ghia P, et al
   Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
   N Engl J Med. 2023;389:33-44.
   PubMed     Abstract available
   
   
   June 2023
9. CHIESA R, Georgiadis C, Syed F, Zhan H, et al
   Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.
   N Engl J Med. 2023 Jun 14. doi: 10.1056/NEJMoa2300709.
   PubMed     Abstract available
   
   
   May 2023
10. FORCONI F, Ashton-Key M, Meakin N
    BCL2 Inhibition in Refractory Hairy-Cell Leukemia.
    N Engl J Med. 2023;388:2010-2012.
    PubMed    
    
    
    
11. WOYACH JA, Byrd JC
    Time-Limited Initial Therapy for Young, Fit Patients with CLL.
    N Engl J Med. 2023;388:1812-1813.
    PubMed    
    
    
    
12. EICHHORST B, Niemann CU, Kater AP, Furstenau M, et al
    First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1739-1754.
    PubMed     Abstract available
    
    
    
13. BROWN JR, Cohen A, Shadman M
    Zanubrutinib in Chronic Lymphocytic Leukemia. Reply.
    N Engl J Med. 2023;388:1720-1721.
    PubMed    
    
    
    
14. LIANG Y, Gale RP
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1720.
    PubMed    
    
    
    
15. BYRD JC, Rothbaum W
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1719-1720.
    PubMed    
    
    
    April 2023
16. VAN DER SLUIS IM, de Lorenzo P, Kotecha RS, Attarbaschi A, et al
    Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.
    N Engl J Med. 2023;388:1572-1581.
    PubMed     Abstract available
    
    
    March 2023
17. TIACCI E, De Carolis L, Santi A, Falini B, et al
    Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia.
    N Engl J Med. 2023;388:952-954.
    PubMed    
    
    
    December 2022
18. BROWN JR, Eichhorst B, Hillmen P, Jurczak W, et al
    Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
    N Engl J Med. 2022 Dec 13. doi: 10.1056/NEJMoa2211582.
    PubMed     Abstract available
    
    
    June 2022
19. MONTESINOS P, de Botton S, Dohner H
    Ivosidenib and Azacitidine in IDH1-Mutated AML. Reply.
    N Engl J Med. 2022;386:2536-2537.
    PubMed    
    
    
    
20. GOODMAN AM, Mohyuddin GR, Prasad V
    Ivosidenib and Azacitidine in IDH1-Mutated AML.
    N Engl J Med. 2022;386:2536.
    PubMed    
    
    
    
21. GIL-SIERRA MD, Briceno-Casado MP, Sierra-Sanchez JF
    Ivosidenib and Azacitidine in IDH1-Mutated AML.
    N Engl J Med. 2022;386:2535-2536.
    PubMed    
    
    
    
22. FOA R, Chiaretti S
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    N Engl J Med. 2022;386:2399-2411.
    PubMed    
    
    
    May 2022
23. RODRIGUES GR, Mendonca TM
    Retinal Hemorrhages in Leukemia.
    N Engl J Med. 2022;386:e50.
    PubMed    
    
    
    April 2022
24. MONTESINOS P, Recher C, Vives S, Zarzycka E, et al
    Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2022;386:1519-1531.
    PubMed     Abstract available
    
    
    February 2022
25. WANG E, Mi X, Thompson MC, Montoya S, et al
    Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.
    N Engl J Med. 2022;386:735-743.
    PubMed     Abstract available
    
    
    January 2022
26. ROGERS E, Cusnir M
    Gingival Infiltration in Acute Monocytic Leukemia.
    N Engl J Med. 2022;386:79.
    PubMed    
    
    
    December 2021
27. GOYAL S, Tisdale J, Schmidt M, Kanter J, et al
    Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.
    N Engl J Med. 2021 Dec 12. doi: 10.1056/NEJMoa2109167.
    PubMed     Abstract available
    
    
    October 2021
28. WOO SB, Wu MY, Treister NS, Amrein PC, et al
    Case 33-2021: A 68-Year-Old Man with Painful Mouth Ulcers.
    N Engl J Med. 2021;385:1700-1710.
    PubMed    
    
    
    September 2021
29. BARRY D, Schmieder A
    Leukemia Cutis.
    N Engl J Med. 2021;385:1316.
    PubMed    
    
    
    August 2021
30. BRUNNER AM, Newcomb RA, Chen YB, Crabbe AM, et al
    Case 26-2021: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia.
    N Engl J Med. 2021;385:834-843.
    PubMed    
    
    
    
31. BEATTY CJ, Ghareeb ER
    Neutrophilic Eccrine Hidradenitis.
    N Engl J Med. 2021;385:e19.
    PubMed    
    
    
    May 2021
32. MARKEWITZ RDH, Dargvainiene J
    Mitotic and Apoptotic Figures on a Peripheral-Blood Smear.
    N Engl J Med. 2021;384:1942.
    PubMed    
    
    
    
33. TIACCI E, De Carolis L, Simonetti E, Capponi M, et al
    Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
    N Engl J Med. 2021;384:1810-1823.
    PubMed     Abstract available
    
    
    
34. MEJIA BURITICA L, Karduss Urueta AJ
    Pulmonary Mucormycosis.
    N Engl J Med. 2021;384:e69.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.